Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis.
about
Small intestinal bacterial overgrowth syndromeNon-alcoholic fatty liver disease: what the clinician needs to know.Insulin resistance in development and progression of nonalcoholic fatty liver diseaseDiet, Microbiota, Obesity, and NAFLD: A Dangerous QuartetThe role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver diseaseGut Microbiota and Host Reaction in Liver DiseasesGut Microbiota and Complications of Liver Disease.Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis.Diagnosis and management of small intestinal bacterial overgrowth.Microbiota and nonalcoholic steatohepatitis.Diagnosis and treatment of small intestinal bacterial overgrowth.Effect of Helicobacter pylori eradication on serum ghrelin and obestatin levels.Microbiota and gut-liver axis: their influences on obesity and obesity-related liver diseaseNon-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome.Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8.A case of nonalcoholic steatohepatitis and small intestinal bacterial overgrowth with peripheral edema caused by intestinal bypass surgery and relieved by repair.
P2860
Q24262889-840FCB0D-21AA-420D-9BEA-FF2868EDE825Q24563068-7DA7C21B-DDFD-484B-A2CC-7D371AD87E15Q26748687-246DE4B9-525F-4B35-A905-EE33974DDA60Q26752614-165438B3-EC51-4337-946B-31D0E9B2CE6AQ26852498-E53E9910-0BDD-41C3-9F43-EEEC50431B52Q28083295-3C5EB1C8-6F84-4C17-B1D3-75B581770FD4Q30236024-EFC53246-29FF-466F-BC84-03523D54B9DFQ30377409-FA740800-5E04-4AFB-B932-56886AD4900EQ33457767-7D3563C0-B067-4027-A05D-F6842F82EA69Q35066721-FDECB58A-B8BD-4F9A-887F-BE28042E7296Q35860893-D5DDC781-E738-4720-9FE1-9AA923B19C90Q36783215-F7799FA1-8947-432F-AD6F-AB62AB1E18AFQ36798196-D31C04C7-214A-4AEF-93D8-83F461B534CBQ37693238-3C40EB8C-C64D-4F47-9AFA-AAD856FDC87CQ38339644-7920BE39-AAC4-41ED-AD58-AFD6037AF49BQ41321756-02CEA68D-608A-46CB-9C68-08AD72C77119
P2860
Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Ciprofloxacin suppresses bacte ...... non-alcoholic steatohepatitis.
@ast
Ciprofloxacin suppresses bacte ...... non-alcoholic steatohepatitis.
@en
Ciprofloxacin suppresses bacte ...... non-alcoholic steatohepatitis.
@nl
type
label
Ciprofloxacin suppresses bacte ...... non-alcoholic steatohepatitis.
@ast
Ciprofloxacin suppresses bacte ...... non-alcoholic steatohepatitis.
@en
Ciprofloxacin suppresses bacte ...... non-alcoholic steatohepatitis.
@nl
prefLabel
Ciprofloxacin suppresses bacte ...... non-alcoholic steatohepatitis.
@ast
Ciprofloxacin suppresses bacte ...... non-alcoholic steatohepatitis.
@en
Ciprofloxacin suppresses bacte ...... non-alcoholic steatohepatitis.
@nl
P2093
P2860
P1476
Ciprofloxacin suppresses bacte ...... non-alcoholic steatohepatitis.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2036.2005.02562.X
P407
P577
2005-08-01T00:00:00Z